<!DOCTYPE html>

<html lang="en">
    <head>
        <title>Proposed implementation</title>
    </head>
    <body>
        <script src="./scripts/wiki.js"></script>
        <!-- <script src="/Template:Ionis_Paris/scripts/wiki?action=raw&ctype=text/javascript"></script> -->

        <div class="navigation"></div>
        <div id="description" x-data="{}" :style="'background-image: url(' + window.LINKS.implementationLogo.url + ')'">
            <div class="container">
                <h1>Proposed implementation - IGEM IONIS</h1>
                <div class="descriptionContent">
                    <div class="descriptionText">
                        <div class="descriptionText1">Proposed</div>
                        <div class="descriptionText2">Implementation</div>
                    </div>
                </div>
            </div>
        </div>
        <div class="seeMore" target-id="implementation"></div>
        <div id="implementation" class="part">
            <div class="container">
                <div class="textContent">
                    <p>
                        Antimicrobial resistance is an urgent healthcare issue. There is an anthropological need
                        embedded in the use of genetically engineered machines.
                    </p>
                    <p>
                        The difficulty in assessing the impacts of Genetically Modified Organisms (GMO) considers the
                        context in which they are used and the possible alternatives to provide the same solutions by
                        other means.
                    </p>
                </div>
            </div>
            <div class="emphaseContent mt-8">
                <div class="container">
                    <div class="textContent font-bold">
                        <p>Our aim is to help face a major healthcare problem: antibiotic resistance. </p>
                    </div>
                </div>
            </div>
            <div class="questionPart mt-16">
                <div class="container">
                    <h2>How are GMOs being used in the pharmaceutical industry?</h2>
                    <div class="textContent mt-6">
                        <p>
                            Currently, GMOs are used as producer organisms for therapeutic molecules of interest. In
                            France, the commercialization of GMOs directly in food for human consumption has not been
                            authorized.
                        </p>
                    </div>
                    <img x-data="{}" :src="window.LINKS.implementation1.url" class="imageContent mt-8" />
                    <div class="textContent mt-6">
                        <p>GMOs used as such as drugs are not authorized. However, some examples in research exist.</p>
                    </div>
                    <div class="gmoList mt-8">
                        <div class="gmoItem">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">
                                    <b>Modified lactic acid bacteria</b> have been administered to rats and successfully
                                    shown major health benefits as they deliver active molecules to the gastrointestinal
                                    tract<sup>1</sup>.
                                </p>
                            </div>
                        </div>
                        <div class="gmoItem mt-6">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">
                                    In April 2019, ZBiotics, a San Francisco-based start-up launched the world’s first
                                    GMO probiotic. They modified a strain of Bacillus subtilis to make it
                                    <b>produce acetaldehyde dehydrogenase</b> in order to break down acetate.
                                    Interestingly, it is regulated as a food and not a drug.
                                </p>
                            </div>
                        </div>
                    </div>
                    <h2 class="mt-16">How are GMOs regulated?</h2>
                    <div class="textContent mt-6">
                        <p>
                            As our project is in synthetic biology, it is
                            <b>directly inspired from living organisms.</b>
                        </p>
                    </div>
                </div>
                <div class="emphaseContent font-bold mt-8">
                    <div class="container">
                        <div class="textContent font-bold">
                            <p>GMOs: strict, specific, country-based regulations</p>
                        </div>
                    </div>
                </div>
                <div class="container">
                    <div class="textContent mt-8">
                        <p>
                            GMOs are only allowed to be manipulated under restricted conditions and are under the
                            responsibility of the researcher. The latter must ensure that no GMO escapes the strictly
                            regulated domain of application and use. Something that will be controlled if the project is
                            only happening in the laboratory.
                        </p>
                    </div>
                    <div class="flex items-center mt-8">
                        <div class="flex-shrink-0">
                            <i data-feather="globe" style="height: 40px; width: 40px"></i>
                        </div>
                        <div class="flex-grow ml-6">
                            <div class="textContent">
                                <p>
                                    In Europe, the main legal frame regarding GMOs is given by the
                                    <b>European Union</b> (EU). According to the <b>Directive 2001/18/EC</b> and
                                    <b>Regulation 1829/2003</b>, it is
                                    <b>prohibited to use or manufacture a GMO without prior specific authorization.</b>
                                </p>
                            </div>
                        </div>
                    </div>
                    <div class="textContent mt-6">
                        <p>Applications for authorization of GMOs fall into three main categories<sup>2</sup>:</p>
                    </div>
                    <div class="categoryList flex flex-col gap-4 mt-8">
                        <div class="categoryItem flex items-center">
                            <div class="categoryOne flex-shrink-0">Contained use</div>
                            <i data-feather="arrow-right" class="categoryTwo flex-shrink-0 ml-6"></i>
                            <div class="categoryThree flex-grow ml-6">
                                <p class="mb-0">
                                    allows GMOs to be used for industrial production or research purposes
                                </p>
                            </div>
                        </div>
                        <div class="categoryItem flex items-center">
                            <div class="categoryOne flex-shrink-0">Use in deliberate release</div>
                            <i data-feather="arrow-right" class="categoryTwo flex-shrink-0 ml-6"></i>
                            <div class="categoryThree flex-grow ml-6">
                                <p class="mb-0">
                                    in the framework of a marketing authorization (feed or food products, GMO seeds and
                                    plants, veterinary medicinal products, gene therapy products, or non-food products
                                    such as flowers)
                                </p>
                            </div>
                        </div>
                        <div class="categoryItem flex items-center">
                            <div class="categoryOne flex-shrink-0">Deliberate release</div>
                            <i data-feather="arrow-right" class="categoryTwo flex-shrink-0 ml-6"></i>
                            <div class="categoryThree flex-grow ml-6">
                                <p class="mb-0">
                                    without placing the product on the market, in the context of experiments such as
                                    field trials or biomedical or veterinary research
                                </p>
                            </div>
                        </div>
                    </div>
                    <div class="mt-16 flex items-center">
                        <div class="france flex-shrink-0 flex items-stretch">
                            <div class="france1"></div>
                            <div class="france2"></div>
                            <div class="france3"></div>
                        </div>
                        <div class="ml-6">
                            <div class="textContent">
                                <p class="mb-0">
                                    In <b>France</b>, authorizations for the use of GMOs need to be issued by specific
                                    authorities depending on the application domain (Agriculture, Consumption, Health,
                                    Research). However, the
                                    <b>Ministry of Ecological and Solidarity Transition</b> (MTES) is always consulted.
                                    Additionally, no matter thef application, an assessment of the potential risks to
                                    human health and the environment is carried out by the
                                    <b>High Council for Biotechnology.</b> This council issues an opinion and/or a
                                    recommendation, depending on the application<sup>3</sup>.
                                </p>
                            </div>
                        </div>
                    </div>
                    <h2 class="mt-16">Safety aspects to consider</h2>
                    <div class="textContent">
                        <p>Risks to consider in regards to our therapeutic probiotic<sup>6</sup>:</p>
                    </div>
                    <div class="flex flex-col riskList mt-6">
                        <div class="riskItem flex items-center">
                            <div class="riskItem1" style="background-color: rgb(173, 11, 43)">1</div>
                            <div class="riskItem2">Must not impact the commensal flora.</div>
                        </div>
                        <div class="riskItem flex items-center">
                            <div class="riskItem1" style="background-color: rgb(173, 87, 11)">2</div>
                            <div class="riskItem2">
                                Make sure that not toxic for human cells (intestinal epithelial cell model).
                            </div>
                        </div>
                        <div class="riskItem flex items-center">
                            <div class="riskItem1" style="background-color: rgb(249, 202, 59)">3</div>
                            <div class="riskItem2">
                                Modification of the intestinal flora: unexpected interactions with bacteria, favor other
                                pathogenic bacteria.
                            </div>
                        </div>
                        <div class="riskItem flex items-center">
                            <div class="riskItem1" style="background-color: rgb(14, 185, 122)">4</div>
                            <div class="riskItem2">Alteration of metabolic functions in the intestinal flora.</div>
                        </div>
                        <div class="riskItem flex items-center">
                            <div class="riskItem1" style="background-color: rgb(14, 162, 185)">5</div>
                            <div class="riskItem2">
                                The survival in the environment and the consequences for public health: the modified
                                bacteria could impact the microbiological environmental equilibrium as well as public
                                health if the soil or animals are contaminated.
                            </div>
                        </div>
                        <div class="riskItem flex items-center">
                            <div class="riskItem1" style="background-color: rgb(62, 14, 185)">6</div>
                            <div class="riskItem2">Potential allergies.</div>
                        </div>
                    </div>
                    <div class="textContent mt-16">
                        <p>How to limit these risks:</p>
                    </div>
                    <div class="gmoList mt-8">
                        <div class="gmoItem">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">
                                    Bacterium should not contain an antibiotic resistance selection marker.
                                </p>
                            </div>
                        </div>
                        <div class="gmoItem mt-6">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">
                                    Genes should be inserted in the genomic chromosome and not contained on a plasmid.
                                    The location of the genes should be precisely known.
                                </p>
                            </div>
                        </div>
                        <div class="gmoItem mt-6">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">Correct analysis of benefit to risk ratio.</p>
                            </div>
                        </div>
                    </div>
                </div>
                <div class="emphaseContent mt-16">
                    <div class="container">
                        <div class="textContent">
                            The design of BacTail was carefully thought through for the outside world.
                            <b>The kill switch is one of the most important parameters in our system</b> as the modified
                            bacteria must be precisely controlled to avoid their dissemination in the environment (<a
                                x-data="{}"
                                :href="window.ROOT_URL + '/Phases/phase3'"
                                >cf. phase 3</a
                            >).
                        </div>
                    </div>
                </div>
                <div class="container">
                    <h2 class="mt-16">To whom is our product dedicated?</h2>
                    <div class="textContent mt-8">
                        <p> Antibiotic resistance affects society.</p>
                    </div>
                    <div class="gmoList mt-6">
                        <div class="gmoItem">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">People suffering with these untreatable bacterial infections</p>
                            </div>
                        </div>
                        <div class="gmoItem mt-6">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">
                                    Healthcare professionals who are powerless and try to cure their patients
                                </p>
                            </div>
                        </div>
                        <div class="gmoItem mt-6">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">Researchers trying to find urgent innovative solutions</p>
                            </div>
                        </div>
                    </div>
                </div>
                <div class="emphaseContent mt-8">
                    <div class="container">
                        <div class="textContent">
                            Our product would not be sold in pharmacies but be directly prescribed by doctors in a
                            hospital setting
                        </div>
                    </div>
                </div>
                <div class="container">
                    <div class="textContent mt-8">
                        <p>
                            After talking with Dr. Blanc-Gruyelle for our Human Practices, we concluded that since our
                            product is tailor-made and would be used in emergency situations, it could not be produced
                            at an industrial scale at first.
                        </p>
                    </div>

                    <img x-data="{}" :src="window.LINKS.implementation2.url" class="mt-6 implementationPathway" />
                    <div class="figureAnnotation mt-2">Figure 1: BacTail and The Patient Pathway</div>
                    <div class="textContent mt-6">
                        <p>
                            After meeting with veterinarians and animal breeders, we also concluded that our product
                            <b>could be administered to animals who are affected by antibiotic resistant infections.</b>
                            In this case, our therapeutic bacteria would be prescribed by veterinarians.
                        </p>
                    </div>

                    <h2 class="mt-16">How would we administer our engineered bacteria to their site of action?</h2>

                    <div class="textContent mt-8">
                        <p>
                            The final goal of our project is to treat bacterial infections caused by antibiotic
                            resistant bacteria.
                        </p>
                        <p>
                            We believe it was important to <b>look at the perspectives of the proof of concept</b> (POC)
                            we were conducting in the lab. That is why, when studying different <b>galenic forms</b>, we
                            opted for a
                            <b>probiotic as an ideal way to reach the lower parts of the gastrointestinal tract</b>,
                            which would usually require sophisticated galenic forms.
                        </p>
                        <p>
                            However, for a product to be qualified as a probiotic, it must conform to several
                            conditions:
                        </p>
                    </div>
                    <img x-data="{}" :src="window.LINKS.implementation3.url" class="mt-6 implementationPathway" />
                    <div class="textContent mt-6">
                        <p>
                            Phase 4 of our project contains all the information regarding the mode of administration for
                            our engineered bacteria (<a x-data="{}" :href="window.ROOT_URL + '/Phases/phase4'"
                                >cf. phase 4</a
                            >).
                        </p>
                    </div>
                    <h2 class="mt-16">BacTail: Proof of Concept and next steps</h2>
                    <div class="textContent font-bold mt-6">
                        <p>
                            POC: conducted on class 1 organisms at first, for safety reasons, with E. coli as our model
                            organism
                        </p>
                    </div>
                    <div class="gmoList mt-6">
                        <div class="gmoItem">
                            <div class="dotContent font-bold">1</div>
                            <div class="gmoContent">
                                <p class="mb-0">
                                    Target and bind <i>E. coli</i> K12 using the LTF of the T4 bacteriophage 
                                </p>
                            </div>
                        </div>
                        <div class="gmoItem mt-6">
                            <div class="dotContent font-bold">2</div>
                            <div class="gmoContent">
                                <p class="mb-0">Kill <i>E. coli</i> K12 by secreting antimicrobial peptides</p>
                            </div>
                        </div>
                        <div class="gmoItem mt-6">
                            <div class="dotContent font-bold">3</div>
                            <div class="gmoContent">
                                <p class="mb-0">Induce the death of our chassis once its mission accomplished</p>
                            </div>
                        </div>
                    </div>
                </div>
                <div class="emphaseContent mt-6">
                    <div class="container">The POC is dedicated to showing that the principle of our system works.</div>
                </div>
                <div class="flex justify-center mt-6">
                    <i data-feather="arrow-down" style="height: 50px; width: 50px"></i>
                </div>
                <div class="container">
                    <div class="textContent mt-6">
                        <p>
                            Further <b>system optimization to increase the precision</b> of the therapeutic bacteria’s
                            action.<br />
                            <b>Fully characterize each step</b> of the POC in the lab (minimal concentration of
                            engineered bacteria needed etc.)
                        </p>
                    </div>
                </div>
                <div class="flex justify-center mt-6">
                    <i data-feather="arrow-down" style="height: 50px; width: 50px"></i>
                </div>
                <div class="emphaseContent mt-6">
                    <div class="container">Next POC using pathogenic bacteria as our target.</div>
                </div>
                <div class="container">
                    <div class="textContent mt-8">
                        <p>
                            We have already found in literature that the
                            <b
                                >PP01 bacteriophage is specific to the shiga-toxin producing strain
                                <i>E. coli</i> O157:H7.</b
                            ><br />
                            That the distal part of the LTF (gp38) is sufficient to specifically bind the pathogenic
                            bacterium and no other ones<sup>4</sup> (<a
                                x-data="{}"
                                :href="window.ROOT_URL + '/Phases/phase1'"
                                >cf. phase 1 perspectives</a
                            >).
                        </p>
                        <p>
                            The idea would be to
                            <b>express the gp38 of the PP01 phage at the surface of our chassis</b> to target the shiga
                            toxin producing strain and kill it by secreting the antimicrobial peptides we have used in
                            our project (MccPDI).
                        </p>
                    </div>
                </div>
                <div class="flex justify-center mt-6">
                    <i data-feather="arrow-down" style="height: 50px; width: 50px"></i>
                </div>
                <div class="container">
                    <div class="textContent mt-6">
                         Test the toxicity in vitro on human cell lines, using <b>intestinal epithelial cell models.</b>
                    </div>
                </div>
                <div class="flex justify-center mt-6">
                    <i data-feather="arrow-down" style="height: 50px; width: 50px"></i>
                </div>
                <div class="emphaseContent mt-6">
                    <div class="container"> In vivo testing on animals (mice, rats)</div>
                </div>
                <div class="container">
                    <div class="textContent mt-6">
                        Inspired from an article published by Geldart et al. 2018<sup>5</sup>
                    </div>
                    <div class="gmoList mt-6">
                        <div class="gmoItem">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">Probiotic must not impact the commensal flora.</p>
                            </div>
                        </div>
                        <div class="gmoItem mt-6">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">Check for side-effects.</p>
                            </div>
                        </div>
                        <div class="gmoItem mt-6">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">Test the action of our probiotic in the gastrointestinal tract.</p>
                            </div>
                        </div>
                        <div class="gmoItem mt-6">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">Evaluate pharmacokinetics.</p>
                            </div>
                        </div>
                        <div class="gmoItem mt-6">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">Test the kill switch reliability.</p>
                            </div>
                        </div>
                    </div>
                    <img x-data="{}" :src="window.LINKS.implementation4.url" class="implementationPathway mt-8" />
                    <div class="figureAnnotation mt-6">
                        Figure 2: In vivo testing process on mice<br />
                        Created with BioRender.com
                    </div>
                </div>
                <div class="flex justify-center mt-6">
                    <i data-feather="arrow-down" style="height: 50px; width: 50px"></i>
                </div>
                <div class="emphaseContent mt-6">
                    <div class="container">
                        Our system would be commercialized as a drug so we would have to follow the traditional standard
                        clinical evaluation phases (patent the system prior to the trails)
                    </div>
                </div>
                <div class="container">
                    <div class="categoryList flex flex-col gap-4 mt-8">
                        <div class="categoryItem flex items-center">
                            <div class="categoryOneBis flex-shrink-0">Phase 1</div>
                            <i data-feather="arrow-right" class="categoryTwo flex-shrink-0 ml-6"></i>
                            <div class="categoryThree flex-grow ml-6">
                                <p class="mb-0">
                                    "Is it safe? Is it tolerable?"<br />
                                    escalating dose response studies on 10-20 healthy volunteers
                                </p>
                            </div>
                        </div>
                        <div class="categoryItem flex items-center">
                            <div class="categoryOneBis flex-shrink-0">Phase 2</div>
                            <i data-feather="arrow-right" class="categoryTwo flex-shrink-0 ml-6"></i>
                            <div class="categoryThree flex-grow ml-6">
                                <p class="mb-0">
                                    "Does it work?"<br />
                                    evaluation of drug effectiveness in 100+ patients with the bacterial infection
                                </p>
                            </div>
                        </div>
                        <div class="categoryItem flex items-center">
                            <div class="categoryOneBis flex-shrink-0">Phase 3</div>
                            <i data-feather="arrow-right" class="categoryTwo flex-shrink-0 ml-6"></i>
                            <div class="categoryThree flex-grow ml-6">
                                <p class="mb-0">
                                    "How well does it work? Common side effects?"<br />
                                    evaluation on 1000+ patients
                                </p>
                            </div>
                        </div>
                        <div class="categoryItem flex items-center">
                            <div class="categoryOneBis flex-shrink-0">Phase 4</div>
                            <i data-feather="arrow-right" class="categoryTwo flex-shrink-0 ml-6"></i>
                            <div class="categoryThree flex-grow ml-6">
                                <p class="mb-0">
                                    Application request for market approval, surveillance for drug adverse effects over
                                    the years.
                                </p>
                            </div>
                        </div>
                    </div>
                </div>
                <div class="flex justify-center mt-6">
                    <i data-feather="arrow-down" style="height: 50px; width: 50px"></i>
                </div>

                <div class="emphaseContent mt-6">
                    <div class="container">
                        However, as mentioned by Dr. Chardon during our Human Practices discussions,
                        <b
                            >we could apply for an emergency use authorization if our preliminary results are
                            promising.</b
                        >
                    </div>
                </div>
                <div class="container">
                    <div class="textContent mt-6">
                        <p>
                            Since our project offers a last resort solution to untreatable bacterial infections which
                            are urgent healthcare issues, it could definitely opt for these types of
                            authorizations<sup>6</sup>.
                        </p>
                    </div>
                    <div class="gmoList mt-6">
                        <div class="gmoItem">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">
                                    <b>Fast Track</b>: "facilitate the development, and expedite the review of drugs to
                                    treat serious conditions and fill an unmet medical need"
                                </p>
                            </div>
                        </div>
                        <div class="gmoItem mt-6">
                            <div class="dotContent"><div class="dotElm"></div></div>
                            <div class="gmoContent">
                                <p class="mb-0">
                                    <b>Breakthrough Therapy</b>: "expedite the development and review of drugs which may
                                    demonstrate substantial improvement over available therapy"
                                </p>
                            </div>
                        </div>
                    </div>
                    <div class="textContent mt-6">
                        <p>
                            Since BacTail is tailor made, meaning the bacterium is modified according to the target
                            pathogen, we would have to <b>approve each of the different engineered bacteria.</b>
                        </p>
                    </div>
                </div>
                <div class="emphaseContent mt-6">
                    <div class="container">
                        <div class="textContent">
                            Furthermore, <b>updates on our software tool</b> (<a
                                x-data="{}"
                                :href="window.ROOT_URL + '/Software'"
                                >cf. software</a
                            >) would have to be done along the years as more and more bacteriophages are being
                            discovered and their specificity properties are being characterized.
                        </div>
                    </div>
                </div>
                <div class="container">
                    <div class="textContent mt-6" x-data="{}">
                        <p>
                            For more information on the
                            <a :href="window.ROOT_URL + '/Proof_Of_Concept'" target="_blank" rel="noopener noreferrer"
                                >proof of concept</a
                            >
                            and how we are implementing our project in the lab: cf.
                            <a :href="window.ROOT_URL + '/Phases/phase1'" target="_blank" rel="noopener noreferrer"
                                >Phase 1</a
                            >,
                            <a :href="window.ROOT_URL + '/Phases/phase2'" target="_blank" rel="noopener noreferrer"
                                >Phase 2</a
                            >,
                            <a :href="window.ROOT_URL + '/Phases/phase3'" target="_blank" rel="noopener noreferrer"
                                >Phase 3</a
                            >
                        </p>
                    </div>
                </div>
            </div>
        </div>
        <div class="references">
            <div class="container">
                <hr />
                <div class="referencesContent">
                    <div class="textContent">
                        <p>
                            [1] Daniel, C. (2016, July). ONE STEP AHEAD: GENETICALLY MODIFIED PROBIOTICS. In Journal of
                            Pediatric Gastroenterology and Nutrition (Vol. 63, No. 1S, p. S42). LWW.
                        </p>
                        <p>
                            [2] Ministère de la Transition écologique. (2019, March). Les organismes génétiquement
                            modifiés (OGM).
                            <a
                                href="https://www.ecologie.gouv.fr/organismes-genetiquement-modifies-ogm-0"
                                target="_blank"
                                rel="noopener noreferrer"
                                >https://www.ecologie.gouv.fr/organismes-genetiquement-modifies-ogm-0</a
                            >
                            Accessed on 18/11/2020.
                        </p>
                        <p>
                            [3]
                            <a
                                href="http://www.hautconseildesbiotechnologies.fr/fr"
                                target="_blank"
                                rel="noopener noreferrer"
                                >http://www.hautconseildesbiotechnologies.fr/fr</a
                            >
                        </p>
                        <p>
                            [4] Yoichi, M., Abe, M., Miyanaga, K., Unno, H., & Tanji, Y. (2005). Alteration of tail
                            fiber protein gp38 enables T2 phage to infect Escherichia coli O157:H7. Journal of
                            Biotechnology, 115(1), 101–107.
                            <a
                                href="https://doi.org/10.1016/j.jbiotec.2004.08.003"
                                target="_blank"
                                rel="noopener noreferrer"
                                >https://doi.org/10.1016/j.jbiotec.2004.08.003</a
                            >
                        </p>
                        <p>
                            [5] Geldart, K. G., Kommineni, S., Forbes, M., Hayward, M., Dunny, G. M., Salzman, N. H., &
                            Kaznessis, Y. N. (2018). Engineered E. coli Nissle 1917 for the reduction of
                            vancomycin‐resistant Enterococcus in the intestinal tract. Bioengineering & translational
                            medicine, 3(3), 197-208.
                        </p>
                        <p>
                            [6] US Food & Drug Administration. (2018). Fast Track, Breakthrough Therapy, Accelerated
                            Approval, Priority Review.
                        </p>
                        <p>
                            [7] Aumaitre, L. A., Besançon, P., Branchard, M., Branlard, G., Corthier, G., Guillemain,
                            J., ... & Paris, A. (2004). OGM et alimentation: peut-on identifier et évaluer des bénéfices
                            pour la santé. Editions de AFSSA, France.
                        </p>
                    </div>
                </div>
            </div>
        </div>
        <footer></footer>
    </body>
    <style>
        html,
        body {
            background-color: #fafafa !important;
        }

        /* Description */

        #description h1 {
            display: none;
        }

        #description {
            display: flex;
            flex-direction: column;
            justify-content: center;
            min-height: 80vh;
            background-repeat: no-repeat;
            background-position: top -80px right -80px;
            background-size: auto 100%;
        }

        .descriptionContent {
            width: 100%;
            display: flex;
            justify-content: flex-start;
            flex-wrap: wrap;
            gap: 20px;
        }

        .descriptionText {
            display: flex;
            flex-direction: column;
            align-items: flex-start;
            justify-content: center;
            text-transform: uppercase;
            font-weight: 800;
            line-height: 1;
        }

        @keyframes description2 {
            0% {
                position: relative;
                top: 200px;
                opacity: 0;
            }

            50% {
                position: relative;
                top: 200px;
                opacity: 0;
            }

            100% {
                position: relative;
                top: 0px;
            }
        }

        .descriptionText2 {
            color: #8d1f24;
            font-size: 50px;
            text-shadow: 0px 10px 20px rgba(141, 31, 37, 0.3);
            animation: description2 2s;
        }

        .descriptionText1 {
            color: #e73327;
            text-shadow: 0px 10px 20px rgba(231, 52, 39, 0.2);
            font-size: 50px;
            animation: description1 1s;
        }

        @keyframes descriptionLogo {
            0% {
                opacity: 0;
            }

            100% {
                opacity: 1;
            }
        }
        @keyframes description1 {
            0% {
                position: relative;
                left: 100px;
                opacity: 0;
            }

            100% {
                position: relative;
                left: 0px;
            }
        }

        /* CONTENT */

        .part {
            margin: 120px 0 40px 0;
        }

        .textContent {
            max-width: 900px;
            font-size: 15px;
        }

        .textContent p {
            margin-bottom: 24px;
            font-size: 17px;
        }

        .textContent p:last-child {
            margin-bottom: 0;
        }

        .emphaseContent {
            background-color: rgba(141, 31, 37, 0.1);
            padding: 60px 0;
        }

        h2 {
            font-size: 20px;
            color: #8d1f24;
            font-weight: 800;
        }

        .imageContent {
            max-width: 900px;
        }

        .gmoList {
            display: flex;
            flex-direction: column;
            max-width: 900px;
            align-items: stretch;
        }

        .gmoItem {
            border-radius: 10px;
            display: flex;
            align-items: stretch;
            background-color: rgba(0, 0, 0, 0.01);
        }

        .dotContent {
            display: flex;
            padding: 20px 20px;
            align-items: center;
            justify-content: center;
        }

        .dotElm {
            height: 8px;
            width: 8px;
            background-color: black;
            border-radius: 99px;
        }

        .gmoItem:hover {
            background-color: rgba(0, 0, 0, 0.03);
        }

        .gmoContent {
            padding: 20px 10px;
        }

        .categoryItem {
            padding: 20px;
            background-color: rgba(0, 0, 0, 0.03);
            border-radius: 10px;
            max-width: 900px;
        }

        .categoryItem:hover {
            background-color: rgba(0, 0, 0, 0.05);
        }

        .categoryOne {
            padding: 5px 10px;
            background-color: rgba(0, 0, 0, 0.05);
            border-radius: 10px;
            width: 240px;
            text-align: center;
        }

        /* FRANCE */

        .france1,
        .france2,
        .france3 {
            width: 30px;
            height: 60px;
        }

        .france1 {
            background-color: #dcdcdc;
        }

        .france2 {
            background-color: #e8e8e8;
        }

        .france3 {
            background-color: #dcdcdc;
        }

        .container a {
            color: #8d1f24 !important;
            text-decoration: none !important;
        }

        .container a:hover {
            color: #8d1f24 !important;
            text-decoration: underline !important;
        }
        /* RISKS */

        .riskList {
            align-items: flex-start;
        }

        .riskItem {
            margin-bottom: 10px;
            padding: 10px;
            border-radius: 5px;
            background-color: white;
            border: 1px solid rgba(0, 0, 0, 0.03);
        }

        .riskItem1 {
            height: 40px;
            width: 40px;
            border-radius: 5px;
            color: white;
            display: flex;
            align-items: center;
            justify-content: center;
            font-weight: 800;
            margin-right: 20px;
            flex-shrink: 0;
        }

        /* IMPLEMENTATION PATHWAY */
        .implementationPathway {
            max-width: 900px;
            width: 100%;
            border-radius: 10px;
            background-color: white;
            padding: 20px;
        }

        .figureAnnotation {
            max-width: 900px;
            text-align: center;
            font-style: italic;
            font-size: 15px;
        }

        .categoryOneBis {
            padding: 5px 10px;
            background-color: rgba(0, 0, 0, 0.05);
            border-radius: 10px;
            width: 110px;
            text-align: center;
        }

        .referencesContent {
            padding: 20px 0;
        }

        .referencesContent .textContent {
            font-size: 13px;
        }
    </style>
</html>
